These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3894728)

  • 1. [Reabsorption of beta 2-microglobulin in the kidney during interferon-induced beta 2-microglobulin overproduction].
    Kawamura J; Higashi Y; Yoshida O
    Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):165-74. PubMed ID: 3894728
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the clinical response of renal cell carcinoma to human lymphoblastoid interferon (MOR-22)].
    Niijima T
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1277-84. PubMed ID: 3782978
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
    Freeman MR
    J Urol; 2007 Jul; 178(1):10-1. PubMed ID: 17574050
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effects of cardiopulmonary by-pass on tubular function--the renal handling of alpha 1-microglobulin and beta 2-microglobulin].
    Murakami A; Funami M; Takaba T; Ishii J; Uzawa R; Takagi Y; Gomi K
    Rinsho Byori; 1987 Nov; 35(11):1257-63. PubMed ID: 2451043
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
    J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.
    Morikawa T; Sugiyama A; Kume H; Ota S; Kashima T; Tomita K; Kitamura T; Kodama T; Fukayama M; Aburatani H
    Clin Cancer Res; 2007 Oct; 13(19):5703-9. PubMed ID: 17908959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of renal cell carcinoma: experimental study and clinical effect].
    Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1988 Nov; 34(11):1879-84. PubMed ID: 3242362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecularly targeted therapies for renal cell cancer: TRAIL research advances.
    Buttyan R; Mian BM
    J Urol; 2007 May; 177(5):1606. PubMed ID: 17437767
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
    Keller G; Schally AV; Gaiser T; Nagy A; Baker B; Halmos G; Engel JB
    Clin Cancer Res; 2005 Aug; 11(15):5549-57. PubMed ID: 16061872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kotake T; Kinouchi T
    Prog Clin Biol Res; 1989; 303():661-9. PubMed ID: 2780667
    [No Abstract]   [Full Text] [Related]  

  • 11. [The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].
    Tsubura E
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):1049-58. PubMed ID: 3463630
    [No Abstract]   [Full Text] [Related]  

  • 12. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.
    Rakhit A; Yeon MM; Ferrante J; Fettner S; Nadeau R; Motzer R; Bukowski R; Carvajal DM; Wilkinson VL; Presky DH; Magram J; Gately MK
    Clin Pharmacol Ther; 1999 Jun; 65(6):615-29. PubMed ID: 10391667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
    Merimsky O; Shnider BI; Chaitchik S
    Mol Biother; 1991 Mar; 3(1):34-7. PubMed ID: 2069758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of interferon, albumin, and beta 2-microglobulin during interferon treatment.
    Sumpio BE; Ernstoff MS; Kirkwood JM
    Cancer Res; 1984 Aug; 44(8):3599-603. PubMed ID: 6378373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased levels of beta 2-microglobulin in blood and urine after interferon treatment].
    Kawamura J; Hashimura T; Ohishi K; Higashi Y; Yoshida O
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2075-84. PubMed ID: 6397546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interferon-based cytokine therapy for advanced renal cell carcinoma].
    Takayama T; Kai F; Sugiyama T; Furuse H; Mugiya S; Ozono S
    Hinyokika Kiyo; 2005 Aug; 51(8):499-502. PubMed ID: 16164263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effects and immunological changes in interferon therapy for advanced renal cell carcinoma].
    Kudo T; Souma H; Kudo S; Kogawa T; Suzuki T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):40-6. PubMed ID: 2109026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
    Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1498-502. PubMed ID: 3141533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on renal dysfunction after intra-arterial hypertensive chemotherapy (CDDP, PEP) for advanced cancer of the uterine cervix--serum.urinary alpha 1-microglobulin, beta 2-microglobulin and urinary lysozyme, albumin].
    Iwanari O; Date Y; Yoshino N; Miyako J; Ryuhkoh K; Moriyama M; Nakayama S; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):115-20. PubMed ID: 1690251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.